Garbsen, July 12, 2023 -The technology company LPKF Laser & Electronics SE and its new biotechnology division ARRALYZE will move into the BioLabs Group's renowned co-working spaces in Boston, USA, this July. BioLabs helps startups bring breakthrough new ideas and technologies to Life-Science markets. In doing so, BioLabs selects only innovations that have the potential to advance the life sciences and make a tangible contribution to improving medical care. For this, Tufts Launchpad | BioLabs was awarded the 2022 Prix Galien USA Award. (www.prnewswire.com/news-releases/biolabs-and-labcentral-win-2022-prix-galien-usa-award-301664861.html)
LPKF has been developing systems and solutions for biomedical applications under the name ARRALYZE for two years. The systems work with glass arrays manufactured with LPKF's proprietary LIDE technology. ARRALYZE offers a complete solution for scalable single cell screening in biomedical research and is one of LPKF's strategic growth initiatives. With its inclusion in BioLabs Boston, ARRALYZE is right at the center of the world's most important biotech network. Hardware and application development for ARRALYZE takes place at LPKF's headquarters in Garbsen near Hanover. For LPKF's CEO Klaus Fiedler, the new lab in Boston is both an award and a stepping stone for ARRALYZE. "The biotech industry is developing rapidly and the United States, especially Boston, has become a center for innovation and scientific progress. Having a presence in Boston gives us the global reach that we need. In addition, the collaboration, networking and knowledge sharing with other startups and industry experts is invaluable to our team." Under the name ARRALYZE, LPKF develops systems and solutions for biomedical applications.
About LPKF LPKF Laser & Electronics SE is a leading provider of laser-based solutions for the technology industry. Laser systems from LPKF are crucial for the production of printed circuit boards, microchips, automotive parts, solar modules and many other components. Founded in 1976, the company is headquartered in Garbsen near Hanover, Germany, and is active worldwide through subsidiaries and representatives. LPKF Laser & Electronics SE shares are traded in the Prime Standard segment of Deutsche Börse (ISIN 0006450000). Contact: Daniel Tolle, Head of Investor Relations & Treasury End of Media Release Issuer: LPKF Laser & Electronics SE Key word(s): Research/Technology
12.07.2023 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | LPKF Laser & Electronics SE |
Osteriede 7 | |
30827 Garbsen | |
Germany | |
Phone: | +49 (0) 5131 7095-0 |
Fax: | +49 (0) 5131 7095-95 |
E-mail: | investorrelations@lpkf.com |
Internet: | www.lpkf.com |
ISIN: | DE0006450000 |
WKN: | 645000 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1678495 |
End of News | EQS Media |
|
1678495 12.07.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.